금융 뉴스 허브
실시간 글로벌 금융 시장 뉴스 · 분석 · 인사이트
BREAKING주요 뉴스
WTI Oil pulls back and hits lows sub-$87 amid bets of a steeper Fed tightening cycle
Oil prices show a moderate pullback on Friday as market expectations that a more aggressive Federal ...
Wall Street Steady Pre-Bell Amid Nvidia CEO Departure; Asia Off, Europe Up
Wall Street futures pointed modesty higher pre-bell Friday, as traders digested the resignation of J...
Gold struggles below $3,900 ahead of US PPI data
Gold (XAU/USD) trims its gains on Friday after briefly climbing above $3,900. The metal fell to $3,8...
Select Water Solutions (WTTR): Buy, Sell, or Hold Post Q2 Earnings?
Select Water Solutions currently trades at $20.23 and has been a dream stock for shareholders. It’s returned 290% since September 2021, blowing past the S&P 500’s 71.6% gain. The company has also beat ...
Mueller Water cut to Sell equivalent at RBC on municipal water spending slowdown
YieldMax BABA Option Income Strategy ETF declares $0.0572 dividend
YieldMax™ AAPL Option Income Strategy ETF declares $0.0694 dividend
YieldMax™ AMZN Option Income Strategy ETF declares $0.051 dividend
YieldMax™ AMD Option Income Strategy ETF declares $0.3906 dividend
Paramount Is One of Today’s Worst S&P 500 Stocks on a Warning Against Mega-Merger
Paramount Skydance and Warner Bros. Discovery long-awaited merger has been at a standstill. Barclays analysts led by Kannan Venkateshwar resumed coverage of both stocks, rating Warner Bros. at Equ ...
S&P 500 Gets Fresh Warning From 5% Treasury Yield
History suggests stock returns weaken sharply around this level
2 Reasons to Like NE and 1 to Stay Skeptical
Over the past six months, Noble Corporation’s shares (currently trading at $44.88) have posted a disappointing 5.8% loss, well below the S&P 500’s 12.9% gain. This was partly due to its softer quarter ...
If a Bear Market Is Coming, History Says This 1 Investing Decision Will Make or Break Your Portfolio
Never give up on stocks during a bear market.
YieldMax AI Option Income Strategy ETF declares $0.1124 dividend
Looming biosimilar void risks $189B in lost U.S. healthcare savings: report